Cancer BiologybioRxivPreprint
Low MSH2 protein levels identify muscle-invasive bladder cancer resistant to cisplatin
Andrew Goodspeed, Annie Jean, James C. Costello
This study identifies low MSH2 protein levels as a marker of cisplatin resistance in bladder cancer using in vitro and clinical data.
DOI 10.1101/359554